Search

everythinglearnresearchcommunity

for

Search:↓

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

The pandemic highlighted the need for accurate information, vaccine development, and adapting to new routines while managing stress and misinformation.

The interdisciplinary approach improved the quality of life for a Parkinson's patient and eased staff workload.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

Eye drops with β-blockers may cause hair loss.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Women with androgenetic alopecia may have higher blood pressure levels.

People with early-onset hair loss have higher risk of heart issues, so early screening is important.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

No treatment is clearly better for central serous chorioretinopathy, and more research is needed.

Clascoterone safely promotes hair growth similar to minoxidil.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.